Digiceutical - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509240763

Publication Date:

September 5, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The digiceuticals market is anticipated to be driven by rising smartphone prevalence in developed and emerging nations, the affordability of digital healthcare technology for both consumers and providers, and a rising desire for integrated health systems and patient-centered treatment
The global market for Digiceutical was estimated to be worth US$ 6124 million in 2023 and is forecast to a readjusted size of US$ 36690 million by 2030 with a CAGR of 29.0% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Digiceutical, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Digiceutical by region & country, by Type, and by Application.
The Digiceutical market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Digiceutical.
麻豆原创 Segmentation
By Company
Pear Therapeutics Inc
Akili Interactive Labs, Inc
Propeller Health
Welldoc
Voluntis
Chrono Therapeutics Inc.
Segment by Type:
Diabetes Management
Substance Abuse
Pulmonary Diseases
Alcohol and Smoking Addiction
Neurological Disorders
Segment by Application
Smartphone
Watches
Medical Device System
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Digiceutical manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Digiceutical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Digiceutical in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Digiceutical Product Introduction
1.2 Global Digiceutical 麻豆原创 Size Forecast
1.3 Digiceutical 麻豆原创 Trends & Drivers
1.3.1 Digiceutical Industry Trends
1.3.2 Digiceutical 麻豆原创 Drivers & Opportunity
1.3.3 Digiceutical 麻豆原创 Challenges
1.3.4 Digiceutical 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Digiceutical Players Revenue Ranking (2023)
2.2 Global Digiceutical Revenue by Company (2019-2024)
2.3 Key Companies Digiceutical Manufacturing Base Distribution and Headquarters
2.4 Key Companies Digiceutical Product Offered
2.5 Key Companies Time to Begin Mass Production of Digiceutical
2.6 Digiceutical 麻豆原创 Competitive Analysis
2.6.1 Digiceutical 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Digiceutical Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digiceutical as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Diabetes Management
3.1.2 Substance Abuse
3.1.3 Pulmonary Diseases
3.1.4 Alcohol and Smoking Addiction
3.1.5 Neurological Disorders
3.2 Global Digiceutical Sales Value by Type
3.2.1 Global Digiceutical Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Digiceutical Sales Value, by Type (2019-2030)
3.2.3 Global Digiceutical Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Smartphone
4.1.2 Watches
4.1.3 Medical Device System
4.2 Global Digiceutical Sales Value by Application
4.2.1 Global Digiceutical Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Digiceutical Sales Value, by Application (2019-2030)
4.2.3 Global Digiceutical Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Digiceutical Sales Value by Region
5.1.1 Global Digiceutical Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Digiceutical Sales Value by Region (2019-2024)
5.1.3 Global Digiceutical Sales Value by Region (2025-2030)
5.1.4 Global Digiceutical Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Digiceutical Sales Value, 2019-2030
5.2.2 North America Digiceutical Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Digiceutical Sales Value, 2019-2030
5.3.2 Europe Digiceutical Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Digiceutical Sales Value, 2019-2030
5.4.2 Asia Pacific Digiceutical Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Digiceutical Sales Value, 2019-2030
5.5.2 South America Digiceutical Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Digiceutical Sales Value, 2019-2030
5.6.2 Middle East & Africa Digiceutical Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Digiceutical Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Digiceutical Sales Value
6.3 United States
6.3.1 United States Digiceutical Sales Value, 2019-2030
6.3.2 United States Digiceutical Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Digiceutical Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Digiceutical Sales Value, 2019-2030
6.4.2 Europe Digiceutical Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Digiceutical Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Digiceutical Sales Value, 2019-2030
6.5.2 China Digiceutical Sales Value by Type (%), 2023 VS 2030
6.5.3 China Digiceutical Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Digiceutical Sales Value, 2019-2030
6.6.2 Japan Digiceutical Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Digiceutical Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Digiceutical Sales Value, 2019-2030
6.7.2 South Korea Digiceutical Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Digiceutical Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Digiceutical Sales Value, 2019-2030
6.8.2 Southeast Asia Digiceutical Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Digiceutical Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Digiceutical Sales Value, 2019-2030
6.9.2 India Digiceutical Sales Value by Type (%), 2023 VS 2030
6.9.3 India Digiceutical Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Pear Therapeutics Inc
7.1.1 Pear Therapeutics Inc Profile
7.1.2 Pear Therapeutics Inc Main Business
7.1.3 Pear Therapeutics Inc Digiceutical Products, Services and Solutions
7.1.4 Pear Therapeutics Inc Digiceutical Revenue (US$ Million) & (2019-2024)
7.1.5 Pear Therapeutics Inc Recent Developments
7.2 Akili Interactive Labs, Inc
7.2.1 Akili Interactive Labs, Inc Profile
7.2.2 Akili Interactive Labs, Inc Main Business
7.2.3 Akili Interactive Labs, Inc Digiceutical Products, Services and Solutions
7.2.4 Akili Interactive Labs, Inc Digiceutical Revenue (US$ Million) & (2019-2024)
7.2.5 Akili Interactive Labs, Inc Recent Developments
7.3 Propeller Health
7.3.1 Propeller Health Profile
7.3.2 Propeller Health Main Business
7.3.3 Propeller Health Digiceutical Products, Services and Solutions
7.3.4 Propeller Health Digiceutical Revenue (US$ Million) & (2019-2024)
7.3.5 Welldoc Recent Developments
7.4 Welldoc
7.4.1 Welldoc Profile
7.4.2 Welldoc Main Business
7.4.3 Welldoc Digiceutical Products, Services and Solutions
7.4.4 Welldoc Digiceutical Revenue (US$ Million) & (2019-2024)
7.4.5 Welldoc Recent Developments
7.5 Voluntis
7.5.1 Voluntis Profile
7.5.2 Voluntis Main Business
7.5.3 Voluntis Digiceutical Products, Services and Solutions
7.5.4 Voluntis Digiceutical Revenue (US$ Million) & (2019-2024)
7.5.5 Voluntis Recent Developments
7.6 Chrono Therapeutics Inc.
7.6.1 Chrono Therapeutics Inc. Profile
7.6.2 Chrono Therapeutics Inc. Main Business
7.6.3 Chrono Therapeutics Inc. Digiceutical Products, Services and Solutions
7.6.4 Chrono Therapeutics Inc. Digiceutical Revenue (US$ Million) & (2019-2024)
7.6.5 Chrono Therapeutics Inc. Recent Developments
8 Industry Chain Analysis
8.1 Digiceutical Industrial Chain
8.2 Digiceutical Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Digiceutical Sales Model
8.5.2 Sales Channel
8.5.3 Digiceutical Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Pear Therapeutics Inc
Akili Interactive Labs, Inc
Propeller Health
Welldoc
Voluntis
Chrono Therapeutics Inc.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.